Transcriptomic Study of IBD-associated Colorectal Cancer

Colorectal Cancer, Genetics of Clinical Trial

Official title:
Transcriptiomic Analysis of Inflammatory Bowel Disease-associated Colorectal Cancer. A French Retrospective Study of 26 Cases Identified at the Nancy University Hospital

Status Completed

Clinical Trial Summary

Chronic inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (CRC) in historical cohorts. The pathways of oncogenesis of these CRCs, which are very different clinically from de novo CRCs, are currently unknown. The aim of our work is to identify specific molecular signatures of CRC occurring in the setting of IBD.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05060770
Study type	Observational [Patient Registry]
Source	Central Hospital, Nancy, France
Contact
Status	Completed
Phase
Start date	January 1, 2010
Completion date	January 1, 2021

View Details

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT04157322` - Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis
	Completed	`NCT01557101` - Comparison Colon Capsule Endoscopy vs Optical Colonoscopy for Colorectal Cancer Screening in Familiar-Risk Population	Phase 4